Volume : 12, Issue : 03, March – 2025
Title:
A COMPARATIVE ANALYSIS OF ANTI-BACTERIAL AND ANTI-FUNGAL ACTIVITY OF POLY HERBAL FORMULATION
Authors :
A.Teja*, V. Naveen Kumar, M.Gowtham, Ganasala.Veera Gowtham, K. Sai Taruni.
Abstract :
Even though pharmacological industries have produced a number of new antibiotics in the last three decades, resistance to these drugs by microorganisms has increased. In general, bacteria have the genetic ability to transmit and acquire resistance to drugs, which are utilized as therapeutic agents. So, the present study is to know that the efficiency of the herbal extracts on Microbial-activity and Anti-fungal activity (Nyctanthes arbortristis, Mentha piperita, salvadora persica). Estimation of Antimicrobial activity by Nutrient agar media, by the technique cup-plate method. In which all the extracts have antibacterial activity. Estimation of anti-fungal activity by potato dextrose agar media, by the inoculation method in which all the extracts have Anti-fungal activity.
Key Words: resistance, herbal extracts, Nyctanthes arbortristis, Mentha piperita, Salvadora persica, Agar media, cup-plate method, potato dextrose agar media, antifungal, antibacterial activity.
Cite This Article:
Please cite this article in press A. Teja et al., A Comparative Analysis Of Anti – Bacterial And Anti – Fungal Activity Of Ploy Herbal Formulation., Indo Am. J. P. Sci, 2025; 12 (03).
Number of Downloads : 10
References:
1. Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical constituents of some Nigerian medicinal plants. African J Biotechnol. 2005;4(7):685–8.
2. Parvin S, Abdul Kader M, Uzzaman Chouduri A, Abu Shuaib Rafshanjani M, Ekramul Haque M, Md Abdul Kader C. Antibacterial, antifungal, and insecticidal activities of the n hexane and ethyl-acetate fractions of methanolic extract of the leaves of Calotropis gigantea Linn. J Pharmacogn Phytochem. 2014;2(5):47–51.
3. Rahman MS, Anwar MN. Antimicrobial Activity of Crude Extract Obtained from the Root of Plumbago zeylanica. Bangladesh J Microbiol. 2007;24(1):73–5.
4. Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V. Inhibiting bacterial drug efflux pumps via phytotherapeutics to combat threatening antimicrobial resistance. Front Microbiol. 2018;9(DEC):1–
5. 18. doi: 10.3389/fmicb.2018.00001. pmid:29403456
6. Poulakou G, Lagou S, Karageorgopoulos DE, Dimopoulos G. New treatments of multidrug resistant Gram-negative ventilator-associated pneumonia. Ann Transl Med. 2018;6(20):423 423. doi: 10.21037/atm.2018.10.29. pmid:30581831.
7. van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence [Internet]. 2017;8(4):460–9. Available from: doi: 10.1080/21505594.2016.1222343. pmid:27593176
8. Falcone M, Paterson D. Spotlight on ceftazidime/avibactam: A new option for MDR Gram negative infections. J Antimicrob Chemother. 2016;71(10):2713–22. doi: 10.1093/jac/dkw239. pmid:27432599
9. Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem [Internet]. 2014;(6):25–64. Available from: doi: 10.4137/PMC.S14459. pmid:25232278
10. Madigan M, Martinko J (editors) (2006). Brock Biology of Microorganisms (13th ed.). Pearson Education. p. 1096.
11. Nitesh RAI, Ludwig W, Schleifer KH (2011). “Phylogenetic identification and in situ detection of individual microbial cells without cultivation”. Microbiology Rev.59 (1): 143–169.
12. Rice G (2007-03-27). “Are Viruses Alive?”. Retrieved 2007-07-23.
13. Penn, M; Dworkin, M (1976). “Robert Koch and two visions of microbiology”.Bacteriological reviews 40 (2): 276–83.
14. Morehead MS, Scarbrough C. Emergence of Global Antibiotic Resistance. Prim Care—Clin Off Pract [Internet]. 2018;45(3):467–84. Available from: doi: 10.1016/j.pop.2018.05.006. pmid:30115335.
15. Dhami N. Trends in Pharmacognosy: A modern science of natural medicines. J Herb Med [Internet]. 2013;3(4):123–31. Available from: http://dx.doi.org/10.1016/j.hermed.2013.06.001
16. Bakal SN, Bereswill S, Heimesaat MM. Finding novel antibiotic substances from medicinal plants— Antimicrobial properties of Nigella sativa directed against multidrug-resistant bacteria. Eur J Microbiol Immunol. 2017;7(1):92–8. doi: 10.1556/1886.2017.00001. pmid:28386474